Abstract
Conventional drug discovery is believed to be much slower than the emerging of diseases. It could also cost pharmaceutical companies hundreds of million of dollars with no guarantee that the process would be a successful one. Therefore, new alternatives for drug discovery methods are urgently required.
Nature has been known as long as human history as very rich sources for various types of human needs including as medicinal sources. By implementing the concept of antigen versus antibody, venom versus antidote somehow taught us that Mother Nature has provided us the cures for every disease. It is just a matter of how to find the right drug for particular disease which is already available in the nature. In the United States of America alone, approximately 50% of drugs recognized by the Food and Drug Administration from the year 1981 until the year 2010 were originated from natural product pure extracts or their derivatives.
This chapter briefly described the power of nature as the abundant sources to find drugs for different kinds of illnesses include the challenges associated with the drug discovery process. By virtue of biodiversity both on land and in oceans, researchers can collect as many as possible extracts (extract library) that can be utilized as medicines through screening process. Drug discovery through screening process utilizing natural products can become a solution of the slow and expensive drug discovery process using conventional way. By the advancement of screening technology such as high throughput screening, thousands of extracts and or bioactive compounds can be screened against different types of diseases only in one day. The availability of extract library allows the acceleration of drug discovery in a faster and cheaper way.
Indonesia as one of the richest country in the world in biodiversity has high potential in providing a large collection of extracts for drug discovery purposes. One of potential plants as medicinal sources is Mangrove. Mangroves and mangrove associates widely spread along roughly 90,000 km Indonesian coastline. Indonesia is home of about 20 family with about hundreds species of mangroves and their associates. Indonesia has the largest mangrove forest or about 23% of total world mangrove forests. Taken altogether, Indonesia offers invaluable medicinal sources. This opens up many opportunities for collaboration among researchers nationally and internationally.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed Y, Sohrab H, Al-Reza SM, Shahidulla Tareq F, Hasan CM, Sattar MA (2010) Antimicrobial and cytotoxic constituents from leaves of Sapium baccatum. Food Chem Toxicol 48:549–552
Arslanyolu M, Erdemgil FZ (2006) Evaluation of the antibacterial activity and toxicity of isolated arctiin from the seeds of Centaurea sclerolepis. J Fac Pharm 35:103–109
Atanasov AG et al (2015) Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv 33(2015):1582–1614
Audah KA (2015) Proceedings of the International conference on innovation, entrepreneurship and technology, 25–26 November, BSD City, Indonesia, ISSN: 2477-1538
Audah KA, Amsyir J, Almasyhur F, Hapsari AM, Sutanto H (2018) Development of extract library from Indonesian biodiversity: exploration of antibacterial activity of mangrove Bruguiera cylindrica leaf extracts. IOP Conf Ser Earth Environ Sci 130(1):012025
Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 6(2):71–79
Balunas MJ, Kinghorn AD (2005) Drug discovery from medicinal plants. Life Sci 78(2005):431–441
Bandaranayake WM (2002) Bioactive compounds and chemicals constituents of mangrove plants. Wet Ecol Manag 10:421–452
Batubara I, Mitsunaga T (2013) Use of Indonesian medicinal plant products against acne. Rev Agric Sci 1:11–30
Batubara I, Darusman LK, Mitsunaga T, Rahminiwati M, Djauhari E (2010) Potency of Indonesian medicinal plants as tyrosinase inhibitor and antioxidant agent. J Biol Sci 10(2):138144
Bindseil KU, Jakupovic J, Wolf D, Lavayre J, Leboul J, van der Pyl D (2001) Pure compound libraries: a new perspective for natural product based drug discovery. Drug Discov Today 6:840–847
Brenk R, Schipani A, James D, Krasowski A, Gilbert IH, Frearson J, Wyatt PG (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3(3):435–444
Butler MS (2004) The role of natural product chemistry in drug discovery. J Nat Prod 67(12):2141–2153
Butler MS (2005) Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 2005(22):162
Butler, R.A., 2016. The top 10 most biodiverse countries: What are the world’s most biodiverse countries? https://news.mongabay.com/2016/05/top-10-biodiverse-countries/ Retreved from internet on April 30, 2018
Cragg GM, Newman DJ (2004) A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J Nat Prod 67(2):232–244
Dandapani S, Rosse G, Southall N, Salvino JM, Thomas CJ (2012) Selecting, acquiring, and using small molecule libraries for high-throughput screening. Curr Protoc Chem Biol 4:177–191. https://doi.org/10.1002/9780470559277.ch110252
Demain AL, Vaishnav P (2011) Natural products for cancer chemotherapy. J Microbial Biotechnol 4(6):687–699
Dickson M, Gagnon JP (2004) Key factors in the rising cost of new drug discovery and development. Nat Rev Drug Discov 3(5):417–429
Do QT, Bernard P (2004) Pharmacognosy and reverse pharmacognosy: a new concept for accelerating natural drug discovery. IDrugs 7(11):1017–1027
de-Faria FM et al (2012) Mechanisms of action underlying the gastric antiulcer activity of the Rhizophora mangle L. J Ethnopharmacol 139(1):234–243
Farnsworth NR, Soejarto DD (2009) Global importance of medicinal plants. In: Akerele O, Heywood V, Synge H (eds) Conservation of medicinal plants, 1st edn. Cambridge University Press, Cambridge, pp 25–52
Frantz S (2005) 2004 approvals: the demise of the blockbuster? Nat Rev Drug Discov 4(2):93–94
Frantz S, Smith A (2003) New drug approvals for 2002. Nat Rev Drug Discov 2(2):95–96
Ganesan A (2004) Natural products as a hunting ground for combinatorial chemistry. Curr Opin Biotechnol 15(6):584–590
Gaudêncio SP, Pereira F (2015) Dereplication: racing to speed up the natural products discovery process. Nat Prod Rep 32:779–810. https://doi.org/10.1039/C4NP00134F
Giri C et al (2011) Status and distribution of mangrove forests of the world using earth observation satellite data. Glob Ecol Biogeogr 20(1):154–159
Graul AI (2001) The year’s new drugs. Drug News Perspect 14(1):12–31
Grynkiewicz G, Achmatowicz O, Pucko W (2000) Bioactive isoflavone—genistein; synthesis and prospective applications. Herba Polon 46:151–160
Guo Z (2017) The modification of natural products for medical use. Acta Pharm Sin B 7(2):119–136
Gurudeeban S et al (2012) Antidiabetic effect of a black mangrove species Aegiceras corniculatum in alloxan-induced diabetic rats. J Adv Pharm Technol Res 3(1):52–56
Harvey AL (2008) Natural products in drug discovery. Drug Discov Today 13:894–901
Hassig CA et al (2014) Ultra-high-throughput screening of natural product extracts to identify proapoptotic inhibitors of Bcl-2 family proteins. J Biomol Screen 19(8):1201–1211
Hughes JP, Rees S, Kalindjian SB, Philpott KL (2011) Principles of early drug discovery. Br J Pharmacol 162:1239–1249
Islam MA et al (2012) Antinociceptive activity of methanolic extract of Acanthus ilicifolius Linn leaves. Turk J Pharm Sci 9(1):51–60
Juyal D, Thawani V, Thaledi S, Joshi M (2014) Ethnomedical properties of Taxus wallichiana Zucc. (Himalayan Yew). J Tradit Complement Med 4(3):159–161
Katiyar C, Gupta A, Kanjilal S, Katiyar S (2012) Drug discovery from plant sources: an integrated approach. Ayu 33(1):10–19
Kazanietz MG (2005) Targeting protein kinase C and “non-kinase” phorbol ester receptors: emerging concepts and therapeutic implications. Biochim Biophys Acta 1754:296
Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4(3):206–220
Kramer R, Cohen D (2004) Functional genomics to new drug targets. Nat Rev Drug Discov 3(11):965–972
Li JW, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325(5937):161–165
Liem AF, Holle E, Gemnafle IY, Wakum DS (2013) Isolasi Senyawa Saponin dari Mangrove Tanjang (Bruguiera gymnorrhiza) dan Pemanfaatannya sebagai Pestisida Nabati pada Larva Nyamuk. Jurnal Biologi Papua 5(1):29–36
Liu Z (2008) Preparation of botanical samples for biomedical research. Endocr Metab Immune Disord Drug Targets 8(2):112–121
Lotsch J, Geisslinger G (2001) Morphine-6-glucuronide: an analgesic of the future? Clin Pharmacokinet 40(7):485–499
Mann J (2000) Murder, magic and medicine, 2nd edn. Oxford University Press, Oxford
Mayorga P, Pérez KR, Cruz SM, Cáceres A (2010) Comparison of bioassays using the anostracean crustaceans Artemia salina and Thamnocephalus platyurus for plant extract toxicity screening. Rev Bras Farmacogn 20:897–903
Mittermeier RA, Gil PR, Hoffman M, Pilgrim J, Brooks T, Mittermeier CG, Lamoreux J, da Fonseca GAB, Seligmann PA, Ford H (2005) Hotspots revisited: earth’s biologically richest and most endangered terrestrial ecoregions. Conservation International, New York
Mouafi FE et al (2014) Phytochemical analysis and antibacterial activity of mangrove leaves (Avicenna marina and Rhizophora stylosa) against some pathogens. World Appl Sci J 29(4):547–554
Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75(3):311–335
Newman DJ, Cragg GM, Sneader KM (2000) The influence of natural products upon drug discovery. Nat Prod Rep 17(3):215–234
Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 66(7):1022–1037
Ochoa-Villarreal M, Howat S, Hong SM, Jang MO, Jin YW, Lee EK, Loake GJ (2016) Plant cell culture strategies for the production of natural products. BMB Rep 49(3):149–158
Okouneva T, Hill BT, Wilson L, Jordan MA (2003) The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol Cancer Ther 2(5):427–436
Pereira DA, Williams JA (2007) Origin and evolution of high throughput screening. Br J Pharmacol 152(1):53–61
Pirttila T, Wilcock G, Truyen L, Damaraju CV (2004) Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer’s disease: multicenter trial. Eur J Neurol 11(11):734–741
Quinn RJ (2012) Basics and principles for building natural product-based libraries for HTS. In: Haian F (ed) Chemical genomics. Cambridge University Press, Cambridge
Rege AA, Chowdhary AS (2013) Evaluation of mangrove plants as putative HIV-protease inhibitors. Indian Drugs 50(7):41
Rohaeti, E et al. (2010) Potensi Ekstrak Rhizophora sp. Sebagai inhibitor tirosinase. Prosiding Semnas Sains III. IPB, Bogor, 13 November, pp 196–201
Roy A, McDonald PR, Sittampalam S, Chaguturu R (2010) Open access high throughput drug discovery in the public domain: a Mount Everest in the making. Curr Pharm Biotechnol 11(7):764–778
Royal Botanical Garden Report (2017) State of the world’s plants. Royal Botanic Gardens, Kew
Safari VZ et al (2016) Antipyretic, antiinflammatory and antinociceptive activities of aqueous bark extract of Acacia nilotica (L.) Delile in albino mice. J Pain Manag Med 2:113
Salim AA et al (2008) Drug discovery from plants. In: Ramawat KG, Mérillon JM (eds) Bioactive molecules and medicinal plants. Springer, Berlin. https://doi.org/10.1007/978-3-540-74603-4_1
Samuelsson G (2004) Drugs of Natural Origin, 5th edn. Apotekarsocieteten, Stockholm
Schroeder FC, Gronquist M (2006) Extending the scope of NMR spectroscopy with microcoil probes. Angew Chem Int Ed 45(43):7122–7131
Singh CR, Kathiresan K (2015) Effect of cigarette smoking on human health and promising remedy by mangroves. Asian Pacific Journal of Tropical Biomedicine 5(2):162–167
Sneader W (2005) Drug discovery: a history. Wiley, Chichester
Tambe VD, Bhambar RS (2016) Studies on diuretics and laxative activity of the Hibiscus tiliaceus Linn. bark extracts. Int J PharmTech Res 9(3):305–310
Tan DS (2004) Current progress in natural product-like libraries for discovery screening. Comb Chem High Throughput Screen 7(7):631–643
Tanvira P, Seenivasan R (2014) Targeting mangrove species as an alternative for snake bite envenomation therapy with special reference to phospholipase A2 inhibitory activity: a mini review. Res J Pharm Biol Chem Sci 5(2):1724–1731
Walters WP, Namchuk M (2003) Designing screens: how to make your hits a hit. Nat Rev Drug Discov 2:259–266
WHO (2005) WHO guidelines for sampling of pharmaceutical products and related materials. WHO Technical Report Series, No. 929
World Health Organization (1996) The World health report : 1996 : fighting disease, fostering development / report of the Director-General.폘Geneva : World Health Organization. http://www.who.int/iris/handle/10665/36848
Yi XX et al (2015) Four new cyclohexylideneacetonitrile derivatives from the hypocotyl of mangrove (Bruguiera gymnorrhiza). Molecules 20(8):14565–14575
Yu D, Suzuki M, Xie L, Morris-Natschke SL, Lee KH (2003) Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med Res Rev 23(3):322–345
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Audah, K.A. (2019). Drug Discovery: A Biodiversity Perspective. In: Siddiquee, S., Melvin, G., Rahman, M. (eds) Nanotechnology: Applications in Energy, Drug and Food. Springer, Cham. https://doi.org/10.1007/978-3-319-99602-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-99602-8_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99601-1
Online ISBN: 978-3-319-99602-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)